Access cutting-edge medication adherence treatment through this clinical trial at a research site in Providence. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Providence location
Preparing your pre-screening questions…
Access medication adherence specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related medication adherence treatment provided free
Check if you qualify for this medication adherence clinical trial in Providence, RI
No-Cost Study Care
Local to Providence
Convenient for RI residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
In this study, the investigators will test the mobile game, Viral Combat, for efficacy and acceptability among diverse participants, ages 15-34 years, receiving PrEP care in clinical settings in New England and Mississippi. Formative evaluation interviews will be conducted with stakeholders (healthcare workers, clinic administrators, and patients taking PrEP) to inform intervention delivery. Data from the formative interviews will also be used to make necessary adaptations to the game and assess acceptability for diverse populations and clinics. Viral Combat will then be further tested with 200 participants ages 15-34 years, receiving PrEP care at clinical sites in the South (n=100 Jackson, MS) and New England (n=100, Providence, RI; Boston, MA) in a multisite Hybrid Type 1 effectiveness-implementation randomized controlled trial (RCT). This trial will test the efficacy of the intervention compared to a control condition (a non-PrEP related game) on biological and behavioral measures. At the end of the trial, a summative evaluation of the implementation context using the i-PARIHS framework will occur. These interviews with study participants and clinic staff will inform future implementation and dissemination of Viral Combat.
Sponsor: Rhode Island Hospital
Yes, this clinical trial (NCT05762705) has an active research site in Providence, RI that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for medication adherence treatment options in Providence, RI, this clinical trial (NCT05762705) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Providence research site is actively enrolling participants for this clinical trial. You'll receive care from experienced medication adherence specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all medication adherence clinical trials near you to find additional studies recruiting in your area.
See all alzheimers disease clinical trials recruiting in Providence — not just this study.
Browse Alzheimers Disease Trials in Providence →